olopatadine hydrochloride

Padagis Israel Pharmaceuticals Ltd🇺🇸 United States

FDA Page

Effective Date: Sep 1, 2023
Approval ID: 126ff6eb-62ae-46f2-ab1e-7ac19346c36b
Products: 0 registered
Version: 10

Regulatory Information

Labeling Type

34391-3

Status

Approved

Full Title

{"content": [{"@styleCode": "bold", "#text": "These highlights do not include all the information needed to use"}, {"@styleCode": "bold", "#text": "OLOPATADINE HYDROCHLORIDE NASAL SPRAY"}, {"@styleCode": "bold", "#text": "OLOPATADINE HYDROCHLORIDE NASAL SPRAY"}, {"@styleCode": "bold", "#text": "OLOPATADINE HYDROCHLORIDE nasal spray, 665 mcg/spray"}], "br": [null, null], "#text": "safely and effectively. See full prescribing information for .\n \n Initial U.S. Approval: 1996"}

Quick Stats

Total Products0

Labelers1

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.